Your browser doesn't support javascript.
loading
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
Windecker, Stephan; Lopes, Renato D; Massaro, Tyler; Jones-Burton, Charlotte; Granger, Christopher B; Aronson, Ronald; Heizer, Gretchen; Goodman, Shaun G; Darius, Harald; Jones, W Schuyler; Aschermann, Michael; Brieger, David; Cura, Fernando; Engstrøm, Thomas; Fridrich, Viliam; Halvorsen, Sigrun; Huber, Kurt; Kang, Hyun-Jae; Leiva-Pons, Jose L; Lewis, Basil S; Malaga, German; Meneveau, Nicolas; Merkely, Bela; Milicic, Davor; Morais, João; Potpara, Tatjana S; Raev, Dimitar; Sabaté, Manel; de Waha-Thiele, Suzanne; Welsh, Robert C; Xavier, Denis; Mehran, Roxana; Alexander, John H.
Afiliación
  • Windecker S; Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Switzerland (S.W.).
  • Lopes RD; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.D.L., T.M., C.B.G., G.H., W.S.J., J.H.A.).
  • Massaro T; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.D.L., T.M., C.B.G., G.H., W.S.J., J.H.A.).
  • Jones-Burton C; Bristol-Myers Squibb, Lawrenceville, NJ (C.J.-B., R.A.).
  • Granger CB; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.D.L., T.M., C.B.G., G.H., W.S.J., J.H.A.).
  • Aronson R; Bristol-Myers Squibb, Lawrenceville, NJ (C.J.-B., R.A.).
  • Heizer G; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.D.L., T.M., C.B.G., G.H., W.S.J., J.H.A.).
  • Goodman SG; Canadian VIGOUR Center, University of Alberta, Edmonton, Canada (S.G.G., R.C.W.).
  • Darius H; Terrence Donnelly Heart Centre, St Michael's Hospital, University of Toronto, Ontario, Canada (S.G.G.).
  • Jones WS; Vivantes Neukoelln Medical Center, Berlin, Germany (H.D.).
  • Aschermann M; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.D.L., T.M., C.B.G., G.H., W.S.J., J.H.A.).
  • Brieger D; Charles University, Prague, Czech Republic (M.A.).
  • Cura F; Concord Clinical School, ANZAC Research Institute, University of Sydney, Australia (D.B.).
  • Engstrøm T; Instituto Cardiovascular de Buenos Aires and Sanatorio Anchorena, Argentina (F.C.).
  • Fridrich V; Rigshospital, University of Copenhagen, Denmark (T.E.).
  • Halvorsen S; National Institute of Cardiovascular Diseases, Bratislava, Slovakia (V.F.).
  • Huber K; Oslo University Hospital Ulleval, University of Oslo, Norway (S.H.).
  • Kang HJ; Wilhelminenhospital and Sigmund Freud University, Medical School, Vienna, Austria (K.H.).
  • Leiva-Pons JL; Seoul National University Hospital, Seoul National University, Korea (H.-J.K.).
  • Lewis BS; Hospital Central Dr Ignacio Morones Prieto, San Luis Potosi, Mexico (J.L.L.-P.).
  • Malaga G; Cardiovascular Clinical Research Institute, Lady Davis Carmel Medical Center, Haifa, Israel (B.S.L.).
  • Meneveau N; CONEVID School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru (G.M.).
  • Merkely B; University Hospital Jean Minjoz, Besançon, France (N.M.).
  • Milicic D; EA3920, University of Burgundy Franche-Comté, Besançon, France (N.M.).
  • Morais J; Semmelweis University Heart and Vascular Center, Budapest, Hungary (B.M.).
  • Potpara TS; University of Zagreb School of Medicine, University Hospital Centre, Croatia (D.M.).
  • Raev D; Hospital de Santo André, Leiria, Portugal (J.M.).
  • Sabaté M; School of Medicine, Belgrade University, Serbia (T.S.P.).
  • de Waha-Thiele S; Clinical Centre of Serbia, Belgrade (T.S.P.).
  • Welsh RC; University Hospital St Anna, Sofia, Bulgaria (D.R.).
  • Xavier D; University Heart Centre Lübeck, University Hospital Schleswig-Holstein, Germany (S.d.W.-T.).
  • Mehran R; German Center for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck, Lübeck (S.d.W.-T.).
  • Alexander JH; Canadian VIGOUR Center, University of Alberta, Edmonton, Canada (S.G.G., R.C.W.).
Circulation ; 140(23): 1921-1932, 2019 12 03.
Article en En | MEDLINE | ID: mdl-31557056
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Pirazoles / Piridonas / Fibrilación Atrial / Inhibidores de Agregación Plaquetaria / Fármacos Cardiovasculares / Aspirina / Síndrome Coronario Agudo / Fibrinolíticos / Intervención Coronaria Percutánea / Anticoagulantes Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Circulation Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Pirazoles / Piridonas / Fibrilación Atrial / Inhibidores de Agregación Plaquetaria / Fármacos Cardiovasculares / Aspirina / Síndrome Coronario Agudo / Fibrinolíticos / Intervención Coronaria Percutánea / Anticoagulantes Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Circulation Año: 2019 Tipo del documento: Article